• Markets
• News
• Learn

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Wedbush analyst David Nierengarten initiated coverage on Telix Pharmaceuticals Limited (NASDAQ:TLX) with an Outperform rating and announced a price target of $22. Telix Pharmaceuticals shares closed at $17.48 on Wednesday. See how other analysts view this stock.
• Jefferies analyst Emma Schwartz initiated coverage on Excelerate Energy, Inc. (NYSE:EE) with a Buy rating and announced a price target of $39. Excelerate Energy shares closed at $29.69 on Wednesday. See how other analysts view this stock.
• Craig-Hallum analyst Albert Lowe initiated coverage on Atossa Therapeutics, Inc. (NASDAQ:ATOS) with a Buy rating and announced a price target of $4. Atossa Therapeutics shares closed at $0.8571 on Wednesday. See how other analysts view this stock.
• Morgan Stanley analyst Joshua Pokrzywinski initiated coverage on Parker-Hannifin Corporation (NYSE:PH) with an Equal-Weight rating and announced a price target of $700. Parker Hannifin shares closed at $665.26 on Wednesday. See how other analysts view this stock.
• Roth Capital analyst Boobalan Pachaiyappan initiated coverage on PolyPid Ltd. (NASDAQ:PYPD) with a Buy rating and announced a price target of $9. PolyPid shares closed at $2.98 on Wednesday. See how other analysts view this stock.

Considering buying EE stock? Here’s what analysts think:

Read This Next:

• Top 2 Defensive Stocks That Are Ticking Portfolio Bombs

Photo via Shutterstock